SPDR S&P Biotech ETF $XBI Shares Sold by Investment House LLC

Investment House LLC lessened its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 16.3% during the third quarter, Holdings Channel reports. The institutional investor owned 75,235 shares of the exchange traded fund’s stock after selling 14,680 shares during the quarter. Investment House LLC’s holdings in SPDR S&P Biotech ETF were worth $11,863,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the company. Bank of America Corp DE boosted its position in SPDR S&P Biotech ETF by 13.3% during the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after acquiring an additional 1,700,851 shares during the last quarter. Main Street Research LLC raised its holdings in shares of SPDR S&P Biotech ETF by 57.4% in the first quarter. Main Street Research LLC now owns 567,479 shares of the exchange traded fund’s stock valued at $72,484,000 after purchasing an additional 206,953 shares during the last quarter. Strs Ohio raised its holdings in shares of SPDR S&P Biotech ETF by 4.9% in the first quarter. Strs Ohio now owns 410,500 shares of the exchange traded fund’s stock valued at $52,433,000 after purchasing an additional 19,300 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in shares of SPDR S&P Biotech ETF by 145.7% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock worth $49,726,000 after purchasing an additional 186,314 shares in the last quarter. Finally, Annex Advisory Services LLC lifted its position in shares of SPDR S&P Biotech ETF by 4.6% in the third quarter. Annex Advisory Services LLC now owns 266,485 shares of the exchange traded fund’s stock worth $42,019,000 after purchasing an additional 11,723 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 0.7%

Shares of XBI opened at $151.64 on Friday. SPDR S&P Biotech ETF has a 12 month low of $106.30 and a 12 month high of $169.89. The firm has a fifty day simple moving average of $157.56 and a 200 day simple moving average of $147.71. The stock has a market capitalization of $10.31 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.